Correlation Between Uniqure NV and Rhythm Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Uniqure NV and Rhythm Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Uniqure NV and Rhythm Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Uniqure NV and Rhythm Pharmaceuticals, you can compare the effects of market volatilities on Uniqure NV and Rhythm Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Uniqure NV with a short position of Rhythm Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Uniqure NV and Rhythm Pharmaceuticals.
Diversification Opportunities for Uniqure NV and Rhythm Pharmaceuticals
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Uniqure and Rhythm is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Uniqure NV and Rhythm Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rhythm Pharmaceuticals and Uniqure NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Uniqure NV are associated (or correlated) with Rhythm Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rhythm Pharmaceuticals has no effect on the direction of Uniqure NV i.e., Uniqure NV and Rhythm Pharmaceuticals go up and down completely randomly.
Pair Corralation between Uniqure NV and Rhythm Pharmaceuticals
Given the investment horizon of 90 days Uniqure NV is expected to generate 4.59 times more return on investment than Rhythm Pharmaceuticals. However, Uniqure NV is 4.59 times more volatile than Rhythm Pharmaceuticals. It trades about 0.11 of its potential returns per unit of risk. Rhythm Pharmaceuticals is currently generating about 0.07 per unit of risk. If you would invest 660.00 in Uniqure NV on November 19, 2024 and sell it today you would earn a total of 758.00 from holding Uniqure NV or generate 114.85% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Uniqure NV vs. Rhythm Pharmaceuticals
Performance |
Timeline |
Uniqure NV |
Rhythm Pharmaceuticals |
Uniqure NV and Rhythm Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Uniqure NV and Rhythm Pharmaceuticals
The main advantage of trading using opposite Uniqure NV and Rhythm Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Uniqure NV position performs unexpectedly, Rhythm Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rhythm Pharmaceuticals will offset losses from the drop in Rhythm Pharmaceuticals' long position.Uniqure NV vs. Rocket Pharmaceuticals | Uniqure NV vs. Rhythm Pharmaceuticals | Uniqure NV vs. Solid Biosciences LLC | Uniqure NV vs. MeiraGTx Holdings PLC |
Rhythm Pharmaceuticals vs. Revolution Medicines | Rhythm Pharmaceuticals vs. Akero Therapeutics | Rhythm Pharmaceuticals vs. Avidity Biosciences | Rhythm Pharmaceuticals vs. Protagonist Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |